title: Role of isoprenoid lipids on the heterotrimeric G protein gamma subunit in determining effector activation.
abstract: Post-translational prenylation of heterotrimeric G protein gamma subunits is essential for high affinity alpha-beta gamma and alpha-beta gamma-receptor interactions, suggesting that the prenyl group is an important domain in the beta gamma dimer. To determine the role of the prenyl modification in the interaction of beta gamma dimers with effectors, the CAAX (where A indicates alipathic amino acid) motifs in the gamma1, gamma2, and gamma11 subunits were altered to direct modification with different prenyl groups. Six recombinant beta gamma dimers were overexpressed in baculovirus-infected Sf9 insect cells, purified, and examined for their ability to stimulate three phospholipase C-beta isozymes and type II adenylyl cyclase. The native beta1 gamma2 dimer (gamma subunit modified with geranylgeranyl) is more potent and effective in activating phospholipase C-beta than either the beta1 gamma1 (farnesyl) or the beta1 gamma11 (farnesyl) dimers. However, farnesyl modification of the gamma subunit in the beta1 gamma2 dimer (beta1 gamma2-L71S) caused a decrement in its ability to activate phospholipase C-beta. In contrast, both the beta1 gamma1-S74L (geranylgeranyl) and the beta1 gamma11-S73L (geranylgeranyl) dimers were more active than the native forms. The beta1 gamma2 dimer activates type II adenylyl cyclase about 12-fold; however, neither the beta1 gamma1 nor the beta1 gamma11 dimers activate the enzyme. As was the case with phospholipase C-beta, the beta1gamma2-L71S dimer was less able to activate adenylyl cyclase than the native beta1 gamma2 dimer. Interestingly, neither the beta1 gamma1-S74L nor the beta1 gamma11-S73L dimers stimulated adenylyl cyclase. The results suggest that both the amino acid sequence of the gamma subunit and its prenyl group play a role in determining the activity of the beta gamma-effector complex.
authors.affiliation: Department of Pharmacology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
authors.forename: C S
authors.initials: CS
authors.lastname: Myung
authors.forename: H
authors.initials: H
authors.lastname: Yasuda
authors.forename: W W
authors.initials: WW
authors.lastname: Liu
authors.forename: T K
authors.initials: TK
authors.lastname: Harden
authors.forename: J C
authors.initials: JC
authors.lastname: Garrison
mesh_terms: D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D016367:Baculoviridae; D002478:Cells, Cultured; D019281:Dimerization; D019204:GTP-Binding Proteins / Q000737:chemistry* / Q000235:genetics / Q000502:physiology*; D007527:Isoenzymes / Q000378:metabolism; D008055:Lipids / Q000737:chemistry* / Q000502:physiology*; D016297:Mutagenesis, Site-Directed; D054799:Phospholipase C beta; D017368:Protein Prenylation; D011499:Protein Processing, Post-Translational; D018411:Spodoptera; D013329:Structure-Activity Relationship; D010738:Type C Phospholipases / Q000378:metabolism
chemical_list: D007527:Isoenzymes; D008055:Lipids; D010738:Type C Phospholipases; D054799:Phospholipase C beta; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases